Breast cancer awareness shouldn’t be limited to October.

Raise your #breastcancerawareness

Genomics is more than family history.

Genetic Technologies is a World Leader in Genetic Risk Assessment. Our brand geneType offers integrated risk testing for a range of serious conditions.

GeneType disease prediction can allow for personalized preventive health plans to manage risk. Early detection can save lives.

Watch Now

Learn more about our breast cancer test with this video featuring Dr. Carolynn Young and Dr. Joel Evans discussing factors that influence breast cancer risk and the clinical utility of geneType for Breast Cancer on The Balancing Act.

Our Suite of Disease Risk Assessments

Get a further understanding of disease risk.

GeneType Multi-Risk Test

Order the full suite of diseases, or customize based on individual needs.

Take the first step towards personalized, preventative healthcare

Click on a test to learn more

 Breast Cancer

GeneType provides lifetime and 5-year risk scores for breast cancer

Colorectal Cancer

GeneType provides lifetime and 10-year risk scores for colorectal cancer

Ovarian Cancer

GeneType provides lifetime and 10-year risk scores for ovarian cancer

Prostate Cancer

GeneType provides lifetime and 5-year risk scores for prostate cancer

Coronary Artery Disease

GeneType provides a 10-year risk score for coronary artery disease

Type 2 Diabetes

GeneType provides an 8-year risk score for type 2 diabetes

 Multi-Risk Suite

Combine and customize the risk panel into a single test

 Mental Health

Powered by Taliaz

Pancreatic Cancer

GeneType provides lifetime and 10-year risk scores for pancreatic cancer

Melanoma

GeneType provides lifetime and 10-year risk scores for melanoma

Atrial Fibrillation
GeneType provides a 10-year risk score for atrial fibrillation

COVID-19 Severity

Offered by Sampled

Know disease risk with geneType risk assessment.

  • Simple saliva collection
  • Clinically actionable results
  • Genetic Counselor post-test consultation available for patient or provider peer-to-peer follow up
  • CLIA certified laboratory providing polygenic risk integrated assessments since 2011

Quality matters
and geneType delivers.

Our expert scientific team has dedicated the last 20 years to translating research into validated clinical tests with actionable outcomes for patients.

Our extensive range of patents, peer-reviewed publications and validated tests reflects this commitment to making personalized, predictive healthcare a reality.

Innovation

GeneType supports the advancement of personalized, preventative healthcare.

The geneType test series outperform traditional risk models.

Let us help you integrate clinical, familial and genetic risk factors to provide a more comprehensive risk profile.

Keep up-to-date with our latest advances 

Sign up to our newsletter to stay informed about our latest advances and how these could support your practice.

    Accredited For Compliance With NPAAC Standards And ISO 15189

    CLIA Number 99D2023356

    A leader in personalized predictive genetics

    Genetic Technologies is invested in the advancement of genomics. We deliver cutting-edge genetic solutions facilitating personalized medicine, introspection, or to fuel basic curiosity of oneself. To learn more about our brands, click on the logos below.